Title
Clinical Manifestation and Assessment of Respiratory Disease,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 3–5 business days
- Estimated Delivery: 6–10 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
The new edition of this popular text has been extensively revised to reflect the latest changes in the field. The introductory chapters address the fundamental skills and protocols necessary for clinical assessment. Each disease is presented in relation to one of six clinical scenarios: atelectasis, consolidation, increased alveolarcapillary membrane thickness, bronchospasm, excessive bronchial secretions, and distal airway and alveolar weakening. Students are provided with an illustration of the major alterations of the lungs, the etiology of the disease, an overview of clinical manifestations, a discussion of management, and a series of self assessment questions. Selfassessment questions to further understanding 4colour inserts New colour plates and detailed artwork Clinical manifestations caused by pathophysiologic mechanisms are highlighted in boxes for easy reference Case studies are included for every chapter that covers a disease to help application of the fundamental information Reorganisation into smaller, more userfriendly chapters Emphasis on clinical scenarios all of the chapters presenting diseases are based on around 6 clinical scenarios: Atelectasis Consolidation Increased alveolarcapillary membrane thickness Bronchospasm Excessive bronchial secretions Distal airway & alveolar weakening Chapters on The Patient Interview; Assessment through TherapistDriven Protocols (TDP); Respiratory Failure New Section: Newborn and Early Childhood Respiratory Diseases
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.